Search

Paul F Zupkas

from San Diego, CA
Age ~73
Get Report
Also known as:
Paul Francis Zupkas, Paul E Zupkas, Paul E Wakim, Paul F Beirne
Phone and address:
5197 Alta Vista St, San Diego, CA 92109
(858) 272-1158
Related to:
Paul Wakim, 79Paule WakimArget F ZupkasMichael E Riehm, 32Sarah K Wakim, 53A F ZupkasBrian E Riehm, 66Joan D ZupkasWilliam R TompkinsStacy D Tompkins, 61Wayne R Zupkas, 71Miriel D Tompkins, 88Christopher P Wakim, 44
Connected to:
Amy Zupko, 59Carla L Zupko, 56Cheryl A Zupko, 45David J Zupko, 73Kathleen F Zupko, 74Laura A Zupko, 52Lindy Zupko, 33Robert L Zupko, 81Sheryl A Zupko, 61Wilma J Zupko, 82

Paul Zupkas Phones & Addresses

  • 5197 Alta Vista St, San Diego, CA 92109 (858) 272-1158
  • 1280 Archer St, San Diego, CA 92109
  • 6450 Lusk Blvd, San Diego, CA 92121
  • 1588 Santa Ana Ave, Costa Mesa, CA 92627
  • 1590 Santa Ana Ave, Costa Mesa, CA 92627
  • 172 22Nd St, Costa Mesa, CA 92627
  • Warner Springs, CA
  • La Mesa, CA
  • Orange, CA
  • Riverside, CA
  • La Jolla, CA
  • 5197 Alta Vista St, San Diego, CA 92109

Work

Company: Uc san diego health 2006 Position: Director, research

Education

School / High School: Rensselaer Polytechnic Institute

Skills

Clinical Research • Public Speaking • Management • Project Management • Device Development • Clinical Studies Coordinator

Industries

Hospital & Health Care

Resumes

Resumes

Paul Zupkas Photo 1

Director, Research

View page
Location:
San Diego, CA
Industry:
Hospital & Health Care
Work:
Uc San Diego Health
Director, Research
Icdx
Chief Technical Officer and Co-Founder
Situs Corporation 1992 - 2002
Chief Technical Officer and Co-Founder
Ivac Corporation 1986 - 1991
Director of Research
Education:
Rensselaer Polytechnic Institute
Skills:
Clinical Research
Public Speaking
Management
Project Management
Device Development
Clinical Studies Coordinator

Publications

Us Patents

Medical Instrument Sheath Comprising A Flexible Ultrasound Transducer

View page
US Patent:
6582368, Jun 24, 2003
Filed:
Apr 17, 2001
Appl. No.:
09/836880
Inventors:
Charles R. Holdaway - San Diego CA
Paul F. Zupkas - San Diego CA, 92109
David G. Matsuura - Escondido CA
Assignee:
Paul F. Zupkas - San Diego CA
C. Lowell Parsons - San Diego CA
International Classification:
A61B 800
US Classification:
600443, 600462
Abstract:
An ultrasound transducer comprises a sheath body constructed from a nonconductive material. The sheath body is configured to be installed over a medical device. A piezoelectric copolymer transducer is held snugly against the medical device by the sheath body when the ultrasound transducer is installed over the medical device. The piezoelectric copolymer transducer transduces incident ultrasound signals into corresponding electric signals. A ground conductor is coupled to a first surface of the piezoelectric copolymer transducer. A signal conductor is coupled to a second surface of the piezoelectric copolymer transducer and conducts the corresponding electric signals to a proximal end of the medical device.

Reinforced Urethral Suppository

View page
US Patent:
7267670, Sep 11, 2007
Filed:
Aug 30, 2001
Appl. No.:
09/943380
Inventors:
S. Grant Mulholland - Birchrunville PA, US
Paul Zupkas - San Diego CA, US
International Classification:
A61M 31/00
US Classification:
604517, 604285, 604286, 604287, 604288
Abstract:
A urethral suppository comprising a non-meltable base member sized to prevent insertion of the base member into the urethra, a non-meltable reinforcement projecting from the base member, and a meltable portion formed around a portion of the reinforcement. The meltable portion tapers along the reinforcement and is shaped for cooperating with the action of the periurethral musculature to retain the suppository within the urethra. A method of delivering one or more therapeutic agents to the female urinary tract, the method involving insertion of the urethral suppository into the urethra. A method for manufacturing a reinforced urethral suppository.

Transluminal Drug Delivery Methods And Devices

View page
US Patent:
20070172507, Jul 26, 2007
Filed:
Jan 26, 2006
Appl. No.:
11/340071
Inventors:
Paul Zupkas - San Diego CA, US
Charles Parsons - San Diego CA, US
International Classification:
A61K 31/737
A61K 31/728
A61K 31/727
A61K 31/24
US Classification:
424423000, 514054000, 514056000, 514536000
Abstract:
Transluminal drug delivery method and device embodiments may include a urethral suppository formulated to treat diseases of the urethra and surrounding organs by enhancing the absorption of a therapeutic agent of the suppository into body tissues without adversely affecting the natural defense mechanisms of these tissues. Adverse affects on the glucosaminoglycan (GAG) barrier by the suppository may be mitigated or eliminated by the presence of a suitable polysaccharide in the suppository.

Transluminal Drug Delivery Methods And Devices

View page
US Patent:
20070172508, Jul 26, 2007
Filed:
Jun 26, 2006
Appl. No.:
11/475809
Inventors:
Paul Zupkas - San Diego CA, US
C. Lowell Parsons - San Diego CA, US
International Classification:
A61K 31/737
A61K 31/728
A61K 31/727
A61K 31/46
A61K 31/24
US Classification:
424423, 514304, 514536, 514 54, 514 56, 514 59
Abstract:
Transluminal drug delivery method and device embodiments can include a urethral suppository formulated to prevent or treat diseases of the urethra and surrounding organs, such as interstitial cystitis or urethritis, by enhancing the absorption of a therapeutic agent of the suppository into body tissues without adversely affecting the natural defense mechanisms of these tissues. Adverse effects on the glycosaminoglycan (GAG) barrier can be mitigated or eliminated by the presence of a suitable polysaccharide in the suppository.

Transluminal Drug Delivery Methods And Devices

View page
US Patent:
20130071445, Mar 21, 2013
Filed:
Sep 14, 2012
Appl. No.:
13/619324
Inventors:
Paul ZUPKAS - San Diego CA, US
C. Lowell Parsons - San Diego CA, US
Assignee:
Kalium, Inc. - San Diego CA
International Classification:
A61K 9/02
A61K 31/727
A61K 31/167
US Classification:
424400, 514626, 514 56
Abstract:
Transluminal drug delivery method and device embodiments can include a urethral suppository formulated to prevent or treat diseases of the urethra and surrounding organs, such as interstitial cystitis or urethritis, by enhancing the absorption of a therapeutic agent of the suppository into body tissues without adversely affecting the natural defense mechanisms of these tissues. Adverse effects on the glycosaminoglycan (GAG) barrier can be mitigated or eliminated by the presence of a suitable polysaccharide in the suppository.

Unitary Venous Return Reservoir With Cardiotomy Filter

View page
US Patent:
46420894, Feb 10, 1987
Filed:
Jan 29, 1985
Appl. No.:
6/696147
Inventors:
Paul F. Zupkas - Costa Mesa CA
Francis M. Servas - San Juan Capistrano CA
Todor Pavlov - Laguna Niguel CA
Steven G. Kelly - Garden Grove CA
Assignee:
Shiley, Inc. - Irvine CA
International Classification:
A61M 3700
US Classification:
604 4
Abstract:
A unitary device for the treatment and collection of blood from two different sources during a surgical procedure comprises a hollow housing made of a rigid, preferably transparent, material, first and second blood inlets in the housing, a first blood treatment element inside the housing comprising a layer of porous defoaming material and a layer of non-woven depth filter material, and a second blood treatment element inside the housing comprising a layer of porous defoaming material and free of any depth filter material. The novel device also includes internal walls for providing two blood flow paths therein, one through the first inlet, the first blood treatment element, a blood collection reservoir defined within the device and a treated blood outlet in the bottom wall of the housing, and the other through the second inlet, the second blood treatment element, the blood collection reservoir and the blood outlet. The latter blood flow path bypasses at least the depth filter material layer of the first blood treatment element. In typical use in an extracorporeal flow circuit, cardiotomy blood is introduced to the first inlet, venous return blood is introduced to the second inlet and the common blood outlet is connected to an extracorporeal blood pump.

Medical Instrument Sheath Comprising A Flexible Ultrasound Transducer

View page
US Patent:
62175181, Apr 17, 2001
Filed:
Oct 1, 1998
Appl. No.:
9/164603
Inventors:
Charles R. Holdaway - San Diego CA
Paul F. Zupkas - San Diego CA
David G. Matsuura - Escondido CA
Assignee:
Situs Corporation - Solana Beach CA
International Classification:
A61B 800
A61B 812
US Classification:
600443
Abstract:
An ultrasound transducer comprises a sheath body constructed from a nonconductive material. The sheath body is configured to be installed over a medical device. A piezoelectric copolymer transducer is held snugly against the medical device by the sheath body when the ultrasound transducer is installed over the medical device. The piezoelectric copolymer transducer transduces incident ultrasound signals into corresponding electric signals. A ground conductor is coupled to a first surface of the piezoelectric copolymer transducer. A signal conductor is coupled to a second surface of the piezoelectric copolymer transducer and conducts the corresponding electric signals to a proximal end of the medical device.

Cryosurgical Instrument

View page
US Patent:
57163537, Feb 10, 1998
Filed:
May 3, 1996
Appl. No.:
8/642658
Inventors:
David G. Matsuura - Escondido CA
Paul F. Zupkas - San Diego CA
Assignee:
URDS, Corp. - San Diego CA
International Classification:
A61B 1738
US Classification:
606 22
Abstract:
A cryosurgical instrument incorporates a heat transfer zone, which abuts against the portion of the cryosurgical instrument near the input refrigerant entrance, and which receives pure input refrigerant at the coldest temperature for quickly and effectively cooling this portion of the cryosurgical instrument. The cryosurgical instrument includes a shaft portion and a handle portion. The shaft portion includes an outer jacket tube having both an open and closed end. The closed end surrounds the freezing zone for freezing live tissue. A middle tube is disposed within the outer jacket tube. An inner tube is disposed within the middle tube. The inner tube is adapted for routing input cryogenic refrigerant therethrough to the freezing zone. The channel between the inner tube and middle tube forms a cryogenic refrigerant exhaust path for exhausting cryogenic refrigerant from the freezing zone. A heat transfer zone is disposed within the handle portion of the cryosurgical instrument near the entrance of the input refrigerant.
Control profile
Paul F Zupkas from San Diego, CA, age ~73 Get Report